By Product
- Enzymes
- Glycosidases
- Neuraminidases
- Glycosyltransferases
- Sialyltransferases
- Others
- Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
- Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
- Instruments
- Mass Spectrometers
- HPLC
- MALDI-TOF
- Array Systems
- Others
By Application
- Drug Discovery and Development
- Disease Diagnostics
- Other Applications
By End User
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
The market is bifurcated into product, application, end user and region. The product segment is categorized into enzymes, instruments, kits, carbohydrates and reagents chemicals. The enzymes segment is predicted to hold the largest glycomics/glycobiology market share owing to the wide range of applications in diagnostics and research and increased sale of these products. The application segment is categorized into drug discovery and development, disease diagnostics and other applications. The drug discovery and development segment is predicted to lead the market and this can be credited to an increased insistence for personalized medicines and emphasis on advanced drug development. The end user segment is fragmented into academic research institutes, pharmaceutical and biotechnology companies and clinical laboratories. The pharmaceutical and biotechnology company segment is anticipated to dominate the market owing to the rise in the number of investments made by these companies for research and development of glycomics.
The North America region is expected to subjugate the market, and this can be primarily credited to increased investments in research activities pertaining to glycomics and a strong presence of key market players in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecasted timeframe owing to the increased healthcare expenditure and operational expanse of biotech and pharma companies in the region.